Miragen Therapeutics, Inc. Made Big Gain
Fri 24 Jan 20 at 05:30 PM
Miragen Therapeutics, Inc. (MGEN:NASDAQ) soared at $0.97, a gain of 42.7%. The stock appeared on our News Catalysts scanner on Thu 23 Jan 20 at 09:35 AM in the 'BIOTECH' category. From Thu 02 Jan 20, the stock recorded 57.14% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Miragen Therapeutics, Inc. (MGEN:NASDAQ)
Miragen Therapeutics Inc is a clinical-stage biopharmaceutical company which engaged in discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics.
Top 10 Gainers:
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 93.33%
- Lianluo Smart Limited (LLIT:NASDAQ), 56.83%
- NanoViricides, Inc. (NNVC:NYSEMKT), 54.48%
- Miragen Therapeutics, Inc. (MGEN:NASDAQ), 42.67%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 33.04%
- BioPharmX Corporation (BPMX:NYSEMKT), 32.4%
- Vaccinex, Inc. (VCNX:NASDAQ), 32.18%
- Mediaco Holding Inc. (MDIA:NASDAQ), 31.11%
- Casa Systems, Inc. (CASA:NASDAQ), 29.2%
- eHealth, Inc. (EHTH:NASDAQ), 26.9%